Further examination using the KM plot database indicated a correlation between elevated MMD levels and unfavorable outcomes in individuals with GC, including age, sex, pathological stage, Lauren classification, treatment, and HER2 status. This evidence concerns the gene ERBB2 and gastric cancer.